AI Drug Discovery Startup Raises $400M
AAAzzam · x · 2026-07-14
A post shares funding news for an AI drug discovery company: it has closed a $400 million Series C round led by Index Ventures, with participation from Kleiner Perkins, Sequoia, DimensionCap, and others.
The concurrent business signal is that the value of AI in drug discovery has shifted from "proof of concept" to "actual deployment." The original post emphasizes that this is no longer just a discussion of future visions, but a transition into the execution phase.
Related event: AI Drug Discovery Firm Chai Raises $400M(3 posts)→
More from Venture
- Beth Kindig says her Q3 AI stocks report flags 5 winners up more than 100% YTD — Beth_Kindig · 2026-07-22
- AI’s economic forecasts are split by nearly a quadrillion dollars by 2035 — bittingthembits · 2026-07-22
- LLM Agent Trader pairs backtesting with model-generated trading signals — tom_doerr · 2026-07-22
- OpenRouter spend data suggests frontier models still capture most paying usage — thedealdirector · 2026-07-21
- AI is collapsing startup and operating costs as U.S. business formation hits a record — sanjaykalra · 2026-07-21
- Soxton lands on investors’ 2026 legal-startup watchlist with $2.5M raised — ashleymayer · 2026-07-21